Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
PLoS One ; 6(5): e18205, 2011.
Article in English | MEDLINE | ID: mdl-21637339

ABSTRACT

Human adenovirus serotype 5 (HAdV5)-based vectors administered intravenously accumulate in the liver as the result of their direct binding to blood coagulation factor X (FX) and subsequent interaction of the FX-HAdV5 complex with heparan sulfate proteoglycan (HSPG) at the surface of liver cells. Intriguingly, the serotype 35 fiber-pseudotyped vector HAdV5F35 has liver transduction efficiencies 4-logs lower than HAdV5, even though both vectors carry the same hexon capsomeres. In order to reconcile this apparent paradox, we investigated the possible role of other viral capsid proteins on the FX/HSPG-mediated cellular uptake of HAdV5-based vectors. Using CAR- and CD46-negative CHO cells varying in HSPG expression, we confirmed that FX bound to serotype 5 hexon protein and to HAdV5 and HAdV5F35 virions via its Gla-domain, and enhanced the binding of both vectors to surface-immobilized hypersulfated heparin and cellular HSPG. Using penton mutants, we found that the positive effect of FX on HAdV5 binding to HSPG and cell transduction did not depend on the penton base RGD and fiber shaft KKTK motifs. However, we found that FX had no enhancing effect on the HAdV5F35-mediated cell transduction, but a negative effect which did not involve the cell attachment or endocytic step, but the intracellular trafficking and nuclear import of the FX-HAdV5F35 complex. By cellular imaging, HAdV5F35 particles were observed to accumulate in the late endosomal compartment, and were released in significant amounts into the extracellular medium via exocytosis. We showed that the stability of serotype 5 hexon:FX interaction was higher at low pH compared to neutral pH, which could account for the retention of FX-HAdV5F35 complexes in the late endosomes. Our results suggested that, despite the high affinity interaction of hexon capsomeres to FX and cell surface HSPG, the adenoviral fiber acted as the dominant determinant of the internalization and trafficking pathway of HAdV5-based vectors.


Subject(s)
Adenoviruses, Human/classification , Adenoviruses, Human/metabolism , Capsid Proteins/metabolism , Factor X/metabolism , Heparitin Sulfate/metabolism , Virus Internalization , Amino Acid Motifs , Animals , CHO Cells , Cell Adhesion , Cell Compartmentation , Cell Membrane/metabolism , Cricetinae , Cricetulus , Endocytosis , Factor X/chemistry , Green Fluorescent Proteins/metabolism , HEK293 Cells , Humans , Intracellular Space/metabolism , Mutation/genetics , Oligopeptides/metabolism , Protein Binding , Protein Structure, Tertiary , Serotyping , Surface Plasmon Resonance , Transduction, Genetic , Virion/metabolism , Virion/ultrastructure
2.
Eur J Immunol ; 41(8): 2185-96, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21538977

ABSTRACT

Adenoviral (Ad) vaccine vectors can generate protective immunity to various pathogens in animal studies. However, recent failures in clinical vaccine trials have underscored the need for a better understanding of how mucosal immune responses to Ad-encoded vaccine Ags are generated in vivo. In this study, we addressed whether directing Ad-encoded ovalbumin (OVA) to different subcellular compartments influences the generation of OVA-specific acquired immunity and the APCs required following i.n. immunization of mice. We show that both secreted and membrane-anchored OVA activate CD4(+) T cells, induce cytotoxic CD8(+) T lymphocytes (CTLs) and generate serum IgG. Additionally, vaginal IgG is induced when OVA is expressed at these subcellular locations, but only the secreted form generates a significant IgA response in the lungs. On the contrary, intracellular expression of OVA efficiently expands CD8(+) T cells but fails to activate CD4(+) T cells, results in poor CTL activity, and does not generate Abs. Finally, we show that regardless of the subcellular localization of OVA, conventional DCs (cDCs) are required for the activation of T cells. However, the direct transduction of conventional DCs is not essential. These findings have important implications for the improvement of Ad vector design and vaccine-induced mucosal immunity.


Subject(s)
Adaptive Immunity/immunology , Adenoviridae/immunology , Antigens/immunology , Dendritic Cells/immunology , Adenoviridae/genetics , Animals , Antigens/genetics , Antigens/metabolism , Cell Line , Cell Line, Tumor , Cross-Priming/immunology , Dendritic Cells/metabolism , Female , Flow Cytometry , Genetic Vectors/genetics , Genetic Vectors/immunology , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/immunology , Green Fluorescent Proteins/metabolism , HEK293 Cells , Humans , Immunization/methods , Immunoglobulin A/immunology , Immunoglobulin A/metabolism , Immunoglobulin G/blood , Immunoglobulin G/immunology , Lung/immunology , Lung/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Ovalbumin/genetics , Ovalbumin/immunology , Ovalbumin/metabolism , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Cytotoxic/metabolism , Transduction, Genetic
3.
Ann N Y Acad Sci ; 1230: E1-E10, 2011 Aug.
Article in English | MEDLINE | ID: mdl-22239475

ABSTRACT

Haemophilus ducreyi and Klebsiella (Calymmatobacterium) granulomatis are sexually transmitted bacteria that cause characteristic, persisting ulceration on external genitals called chancroid and granuloma inguinale, respectively. Those ulcers are endemic in developing countries or exist, as does granuloma inguinale, only in some geographic "hot spots."H. ducreyi is placed in the genus Haemophilus (family Pasteurellacae); however, this phylogenetic position is not obvious. The multiple ways in which the bacterium may be adapted to its econiche through specialized nutrient acquisitions; defenses against the immune system; and virulence factors that increase attachment, fitness, and persistence within genital tissue are discussed below. The analysis of K. granulomatis phylogeny demonstrated a high degree of identity with other Klebsiella species, and the name K. granulomatis comb. nov. was proposed. Because of the difficulty in growing this bacterium on artificial media, its characteristics have not been sufficiently defined. More studies are needed to understand bacterial genetics related to the pathogenesis and evolution of K. granulomatis.


Subject(s)
Evolution, Molecular , Haemophilus ducreyi/genetics , Klebsiella/genetics , Sexually Transmitted Diseases, Bacterial/microbiology , Animals , Chancroid/genetics , Chancroid/microbiology , Chancroid/transmission , Genetic Variation , Haemophilus ducreyi/pathogenicity , Haemophilus ducreyi/physiology , Humans , Klebsiella/pathogenicity , Klebsiella/physiology , Klebsiella Infections/genetics , Klebsiella Infections/microbiology , Klebsiella Infections/transmission , Phylogeny , Virulence Factors/genetics , Virulence Factors/physiology
4.
APMIS ; 118(2): 143-9, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20132178

ABSTRACT

The Haemophilus ducreyi cytolethal distending toxin (HdCDT) catalytic subunit CdtB has DNase-like activity and mediates DNA damage after its delivery into target cells. We constructed a replication-deficient adenovirus type 5 (Ad5) vector expressing CdtB and investigated the toxic properties of this vector on HeLa cells. Ad5CdtB caused loss of cell viability, morphologic changes, and cell cycle arrest, findings similar to HdCDT intoxication. This confirmed that CdtB is responsible for the toxicity of the holotoxin when expressed in cells following transduction by an adenoviral vector, and indicated a possible potential of this novel strategy in studies of activity of intracellular products and in gene therapy of cancer.


Subject(s)
Adenoviridae/genetics , Bacterial Toxins/toxicity , Genetic Vectors , Haemophilus ducreyi/pathogenicity , Bacterial Toxins/genetics , HeLa Cells , Humans
5.
Hum Gene Ther ; 21(7): 795-805, 2010 Jul.
Article in English | MEDLINE | ID: mdl-19947826

ABSTRACT

Prostate cancer is a leading cause of death among men in Western countries. Whereas the survival rate approaches 100% for patients with localized cancer, the results of treatment in patients with metastasized prostate cancer at diagnosis are much less successful. The patients are usually presented with a variety of treatment options, but therapeutic interventions in prostate cancer are associated with frequent adverse side effects. Gene therapy and oncolytic virus therapy may constitute new strategies. Already a wide variety of preclinical studies has demonstrated the therapeutic potential of such approaches, with oncolytic prostate-specific adenoviruses as the most prominent vector. The state of the art and future prospects of gene therapy in prostate cancer are reviewed, with a focus on adenoviral vectors. We summarize advances in adenovirus technology for prostate cancer treatment and highlight areas where further developments are necessary.


Subject(s)
Adenoviridae/genetics , Genetic Therapy , Genetic Vectors/genetics , Prostatic Neoplasms/therapy , Genetic Therapy/methods , Genetic Therapy/trends , Humans , Male
6.
Hum Gene Ther ; 21(3): 251-69, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19788389

ABSTRACT

In vivo gene transfer to the human respiratory tract by adenovirus serotype 5 (Ad5) vectors has revealed their limitations related to inefficient gene transfer, host antiviral response, and innate adenoviral toxicity. In the present work, we compared the cytotoxicity and efficiency of Ad5 and a chimeric Ad5F35 vector with respect to CFTR gene transfer to cystic fibrosis (CF) and non-CF human airway epithelial cells. We found that high doses of Ad5 vector had an adverse effect on the function of exogenous and endogenous CFTR. Results obtained with Ad5 capsid mutants suggested that the RGD motifs on the penton base capsomers were responsible for the negative effect on CFTR function. This negative interference did not result from a lower level of biosynthesis and/or altered cellular trafficking of the CFTR protein, but rather from an indirect mechanism of functional blockage of CFTR, related to the RGD integrin-mediated endocytic pathway of Ad5. No negative interference with CFTR was observed for Ad5F35, an Ad5-based vector pseudotyped with fibers from Ad35, a serotype that uses another cell entry pathway. In vitro, Ad5F35 vector expressing the GFP-tagged CFTR (Ad5F35-GFP-CFTR) showed a 30-fold higher efficiency of transduction and chloride channel correction in CFTR-deficient cells, compared with Ad5GFP-CFTR. Ex vivo, Ad5F35-GFP-CFTR had the capacity to transduce efficiently reconstituted airway epithelia from patients with CF (CF-HAE) via the apical surface, restored chloride channel function at relatively low vector doses, and showed relatively stable expression of GFP-CFTR for several weeks.


Subject(s)
Adenoviridae/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/therapy , Genetic Therapy , Genetic Vectors , Respiratory Mucosa/metabolism , Adult , Blotting, Western , Capsid Proteins/physiology , Cells, Cultured , Chlorides/metabolism , Cystic Fibrosis/genetics , Cystic Fibrosis/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Endocytosis , Gene Transfer Techniques , Genome, Viral , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Integrins/metabolism , Mutation/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Respiratory Mucosa/pathology , Reverse Transcriptase Polymerase Chain Reaction , Transgenes/physiology
7.
Hum Gene Ther ; 21(7): 807-13, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20001452

ABSTRACT

Prostate cancer is at present the most common malignancy in men in the Western world. When localized to the prostate, this disease can be treated by curative therapy such as surgery and radiotherapy. However, a substantial number of patients experience a recurrence, resulting in spreading of tumor cells to other parts of the body. In this advanced stage of the disease only palliative treatment is available. Therefore, there is a clear clinical need for new treatment modalities that can, on the one hand, enhance the cure rate of primary therapy for localized prostate cancer and, on the other hand, improve the treatment of metastasized disease. Gene therapy is now being explored in the clinic as a treatment option for the various stages of prostate cancer. Current clinical experiences are based predominantly on trials with adenoviral vectors. As the first of a trilogy of reviews on the state of the art and future prospects of gene therapy in prostate cancer, this review focuses on the clinical experiences and progress of adenovirus-mediated gene therapy for this disease.


Subject(s)
Adenoviridae/genetics , Genetic Therapy/methods , Prostatic Neoplasms/therapy , Genetic Therapy/trends , Humans , Male , Neoplasm Staging , Prostatic Neoplasms/radiotherapy , Prostatic Neoplasms/surgery , Treatment Outcome
8.
J Gene Med ; 11(11): 990-1004, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19757488

ABSTRACT

BACKGROUND: Many studies aimed at retargeting adenovirus (Ad) rationally focus on genetic modification of fiber, which is the primary receptor-binding protein of Ad. Retargeted fibers ultimately require functional validation in the viral context. METHODS: Lentiviral vectors (LV) were used to express fiber variants in cells. Infections with a fiber gene-deleted Ad vector yielded fiber-pseudotyped viruses. An enzyme-linked immunosorbent assay and slot blot-based assays probed target binding-ability of retargeted fibers. Differential treatments with an alkylating agent prior to western blot analysis allowed for examination of intra- and extracellular redox states of fibers. RESULTS: In the present study, LV-based fiber-pseudotyping of Ad is presented as an accelerated means to test new fibers. LV-mediated gene transfer yielded stable and uniform populations of fiber variant-expressing cells. These populations were found to effectively support fiber-pseudotyping of Ad. As a secondary objective of the study, we functionally assessed a chimeric fiber harboring a tumor antigen-directed single-chain antibody fragment (scFv). This fiber was shown to trimerize and achieve a degree of binding to its antigenic target. However, its capsid incorporation ability was impaired and, moreover, it was unable to confer a detectable level of target binding upon Ad. Importantly, subsequent analyses of this fiber revealed the improper folding of its scFv constituent. CONCLUSIONS: LV-based fiber-pseudotyping was established as a convenient method for testing modified fibers for functionality within Ad particles. Furthermore, a new chimeric fiber was found to be inadequate for Ad retargeting. The folding difficulties encountered for this particular fiber might be generally inherent to the use (i.e. for genetic Ad capsid incorporation) of complex, disulfide bridge-containing natural ligands.


Subject(s)
Adenoviridae/genetics , Genetic Vectors/genetics , Lentivirus/genetics , Transduction, Genetic , Adenoviridae/metabolism , Cells, Cultured , Gene Transfer Techniques , Genetic Vectors/metabolism , Lentivirus/metabolism , Single-Chain Antibodies/genetics , Single-Chain Antibodies/immunology
9.
J Virol ; 83(12): 6048-66, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19357170

ABSTRACT

Taking advantage of the wide tropism of baculoviruses (BVs), we constructed a recombinant BV (BV(CAR)) pseudotyped with human coxsackie B-adenovirus receptor (CAR), the high-affinity attachment receptor for adenovirus type 5 (Ad5), and used the strategy of piggybacking Ad5-green fluorescent protein (Ad5GFP) vector on BV(CAR) to transduce various cells refractory to Ad5 infection. We found that transduction of all cells tested, including human primary cells and cancer cell lines, was significantly improved using the BV(CAR)-Ad5GFP biviral complex compared to that obtained with Ad5GFP or BV(CAR)GFP alone. We determined the optimal conditions for the formation of the complex and found that a high level of BV(CAR)-Ad5GFP-mediated transduction occurred at relatively low adenovirus vector doses, compared with transduction by Ad5GFP alone. The increase in transduction was dependent on the direct coupling of BV(CAR) to Ad5GFP via CAR-fiber knob interaction, and the cell attachment of the BV(CAR)-Ad5GFP complex was mediated by the baculoviral envelope glycoprotein gp64. Analysis of the virus-cell binding reaction indicated that the presence of BV(CAR) in the complex provided kinetic benefits to Ad5GFP compared to the effects with Ad5GFP alone. The endocytic pathway of BV(CAR)-Ad5GFP did not require Ad5 penton base RGD-integrin interaction. Biodistribution of BV(CAR)-Ad5Luc complex in vivo was studied by intravenous administration to nude BALB/c mice and compared to Ad5Luc injected alone. No significant difference in viscerotropism was found between the two inocula, and the liver remained the preferred localization. In vitro, coagulation factor X drastically increased the Ad5GFP-mediated transduction of CAR-negative cells but had no effect on the efficiency of transduction by the BV(CAR)-Ad5GFP complex. Various situations in vitro or ex vivo in which our BV(CAR)-Ad5 duo could be advantageously used as gene transfer biviral vector are discussed.


Subject(s)
Adenoviruses, Human/genetics , Baculoviridae/genetics , Genetic Vectors , Receptors, Virus/genetics , Transduction, Genetic , Adenoviruses, Human/ultrastructure , Animals , Baculoviridae/ultrastructure , Cell Line , Coxsackie and Adenovirus Receptor-Like Membrane Protein , Female , Green Fluorescent Proteins/genetics , Humans , Mice , Mice, Inbred BALB C , Mice, Nude , Recombinant Fusion Proteins/genetics
10.
PLoS One ; 3(8): e2894, 2008 Aug 06.
Article in English | MEDLINE | ID: mdl-18682854

ABSTRACT

Intranuclear crystalline inclusions have been observed in the nucleus of epithelial cells infected with Adenovirus serotype 5 (Ad5) at late steps of the virus life cycle. Using immuno-electron microscopy and confocal microscopy of cells infected with various Ad5 recombinants modified in their penton base or fiber domains, we found that these inclusions represented crystals of penton capsomers, the heteromeric capsid protein formed of penton base and fiber subunits. The occurrence of protein crystals within the nucleus of infected cells required the integrity of the fiber knob and part of the shaft domain. In the knob domain, the region overlapping residues 489-492 in the FG loop was found to be essential for crystal formation. In the shaft, a large deletion of repeats 4 to 16 had no detrimental effect on crystal inclusions, whereas deletion of repeats 8 to 21 abolished crystal formation without altering the level of fiber protein expression. This suggested a crucial role of the five penultimate repeats in the crystallisation process. Chimeric pentons made of Ad5 penton base and fiber domains from different serotypes were analyzed with respect to crystal formation. No crystal was found when fiber consisted of shaft (S) from Ad5 and knob (K) from Ad3 (heterotypic S5-K3 fiber), but occurred with homotypic S3K3 fiber. However, less regular crystals were observed with homotypic S35-K35 fiber. TB5, a monoclonal antibody directed against the Ad5 fiber knob was found by immunofluorescence microscopy to react with high efficiency with the intranuclear protein crystals in situ. Data obtained with Ad fiber mutants indicated that the absence of crystalline inclusions correlated with a lower infectivity and/or lower yields of virus progeny, suggesting that the protein crystals might be involved in virion assembly. Thus, we propose that TB5 staining of Ad-infected 293 cells can be used as a prognostic assay for the viability and productivity of fiber-modified Ad5 vectors.


Subject(s)
Adenoviridae/genetics , Viral Proteins/isolation & purification , Adenoviridae/pathogenicity , Adenoviridae/ultrastructure , Antigens, Viral/genetics , Antigens, Viral/metabolism , Cell Nucleus/ultrastructure , Conserved Sequence , Genetic Vectors , Humans , KB Cells/ultrastructure , Microscopy, Electron , Microscopy, Immunoelectron , Viral Proteins/chemistry , Virion
11.
Mol Ther ; 15(11): 2008-16, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17653105

ABSTRACT

Transient overexpression of genes involved in lung regulation might prevent alveolar developmental disorders (ADDs) in premature neonates. However, adenovirus 5 (Ad5) vectors per se, and not isolated capsid proteins, induce ADDs after tracheal administration to newborn rats. To test the hypothesis that Ad5 capsid components are mainly responsible for ADDs, we evaluated newborn rats' lung development by morphometry after tracheal administration of a panel of Ad5 vectors with mutations in the fiber or penton base. Three distinct patterns of lung response were observed on postnatal day (PD) 21: (i) emphysematous-like lesions, common to Ad5 overexposing RGD motifs; (ii) altered septation, representative of the wild-type capsid Ad5 lesion; (iii) absence of lung toxicity, shown by Ad5 vectors with fibers shortened to seven repeats. None of these patterns correlated with the degree of lung inflammation or gene transduction. In contrast, a more impaired elastogenesis associated with emphysema was preceded by a significantly increased level of activated caspase 3 on PD11. Moreover, the altered septation was associated with a persistent and significant increase in terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive alveolar septal cells on PD21. Our results underline the deleterious effects of Ad-induced apoptosis, which is not only responsible for limited transgene expression but also involved in lung development disorders.


Subject(s)
Adenoviridae/genetics , Capsid Proteins/metabolism , Genetic Vectors/genetics , Genetic Vectors/toxicity , Lung/cytology , Lung/growth & development , Animals , Capsid Proteins/genetics , Caspase 3/metabolism , Cell Line , Cell Shape , Humans , Infant, Newborn , Pneumonia/enzymology , Pneumonia/pathology , Rats , Rats, Sprague-Dawley , Transduction, Genetic
12.
J Gen Virol ; 87(Pt 11): 3151-3160, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17030847

ABSTRACT

Adenovirus serotype 5 (Ad5) vectors carrying knobless fibers designed to remove their natural tropism were found to have a lower fiber content than recombinant Ad5 with wild-type (WT) capsid, implying a role for the knob-coding sequence or/and the knob domain in fiber encapsidation. Experimental data using a variety of fiber gene constructs showed that the defect did not occur at the fiber mRNA level, but at the protein level. Knobless fiber proteins were found to be synthesized at a significant slower rate compared with knob-carrying fibers, and the trimerization process of knobless fibers paralleled their slow rate of synthesis. A recombinant Ad5 diploid for the fiber gene (referred to as Ad5/R7-ZZ(wt)/E1 : WT-fiber) was constructed to analyse the possible rescue of the knobless low-fiber-content phenotype by co-expression of WT fiber. Ad5/R7-ZZ(wt)/E1 : WT-fiber contained a knobless fiber gene in its natural location (L5) in the viral genome and an additional WT fiber gene in an ectopic position in E1. Knobless fiber was still synthesized at low levels compared with the co-expressed E1 : WT fiber and the recovery of the two fiber species in virus progeny reflected their respective amounts in the infected cells. Our results suggested that deletion of the fiber knob domain had a negative effect on the translation of the fiber mRNA and on the intracellular concentration of fiber protein. They also suggested that the knob control of fiber protein synthesis and encapsidation occurred as a cis effect, which was not modified by WT fiber protein provided in trans by the same Ad5 genome.


Subject(s)
Adenoviridae/metabolism , Antigens, Viral/biosynthesis , Capsid Proteins/biosynthesis , Capsid/metabolism , Adenoviridae/genetics , Antigens, Viral/chemistry , Capsid Proteins/chemistry , Cell Line , Gene Deletion , Genetic Vectors/metabolism , Humans , Protein Structure, Tertiary/genetics , Protein Structure, Tertiary/physiology
13.
Biotechnol Appl Biochem ; 45(Pt 2): 93-105, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16712522

ABSTRACT

To evaluate the possibility of generating novel proteins binding to highly glycosylated viral proteins, affibody ligands were selected by bacteriophage display technology to the HIV-1 envelope glycoprotein gp120 (glycoprotein 120), from a combinatorial protein library based on the 58-amino-acid-residue staphylococcal Protein A domain. The predominant variant from the bacteriophage selection was produced in Escherichia coli and characterized by biosensor analyses. Both univalent and bivalent affibody molecules were shown to bind selectively to the gp120 target molecule in a biosensor analysis. The dissociation equilibrium constants (KD) were determined to be approx. 100 nM for the univalent affibody and 10 nM for the bivalent affibody, confirming the stronger gp120 binding of the bivalent affibody ligand. The affibody constructs were further introduced into the Ad5 (adenovirus type 5) fibre gene, and the recombinant fibres were shown to bind selectively to gp120 in a biosensor analysis and to gp160 transiently expressed in African-green-monkey (Cercopithecus aethiops) kidney cells. Neither the affibody ligand nor the Ad5 fibres showed any virus neutralization activity, suggesting that the affibody bound to a non-neutralizing site on gp120. To investigate the binding site for the affibody ligand on gp120, CD4 (cluster of differentiation 4) and a panel of mAbs (monoclonal antibodies) known to bind to gp120 were allowed to compete with the affibody ligand in a biosensor study. Two mAbs, 670-30D and 697-30D, were found to compete with gp120 for overlapping binding sites. Although neutralization effects were not achieved in this initial investigation, the successful selection of a gp120-binding affibody ligand indicates that future affibody-based strategies might evolve to complement antibody-based efforts for HIV-1 therapy. Strategies for directed selection of affibody ligands binding to neutralizing epitopes and the potential of using adenovirus for gene-therapy-mediated efforts are discussed.


Subject(s)
HIV Envelope Protein gp120/immunology , Recombinant Fusion Proteins/chemistry , Adenoviridae/genetics , Amino Acid Sequence , Animals , Antibodies, Monoclonal/chemistry , Binding Sites , Binding, Competitive , Biosensing Techniques , CD4 Antigens/chemistry , Cell Line , Chlorocebus aethiops , Dimerization , Epitope Mapping , Fluorescent Antibody Technique , HIV Envelope Protein gp120/chemistry , HIV Envelope Protein gp120/metabolism , HIV-1/immunology , Humans , Ligands , Molecular Sequence Data , Neutralization Tests , Peptide Library , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
14.
J Gene Med ; 8(2): 147-54, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16288495

ABSTRACT

BACKGROUND: The adenovirus 14.3 kDa hexon-associated protein IX (pIX) functions in the viral capsid as 'cement' and assembles the hexons in stable groups-of-nine (GONs). Although viruses lacking pIX do not form GONs, and are less heat-stable than wild-type (wt) viruses, they can be propagated with the same kinetics and yields as the wt viruses. To facilitate 'pseudotyping' of adenoviral vectors we have set up an efficient system for the generation of pIX-producing helper cell lines. METHODS: With a lentiviral pIX-expression cassette, monoclonal and polyclonal helper cell lines were generated, which express wt or modified pIX genes at levels equivalent to wt HAdV-5 infected cells. The incorporation efficiency into pIX gene deleted viruses was examined by Western analysis, immuno-affinity electron microscopy, and heat-stability assays. RESULTS: Immuno-affinity electron microscopy on viruses lacking the pIX gene demonstrated that more than 96% of the particles contain pIX protein in their capsids after propagation on the pIX-expressing helper cell lines. In addition, the pIX level in the helper cells was sufficient to generate heat-stable particles. Finally, the ratio between pIX and fiber was equivalent to that found in wt particles. The pIX-producing cell lines are very stable, demonstrating that pIX is not toxic to cells. CONCLUSION: These data demonstrate that lentivirus vectors can be used for the establishment of pIX-complementing helper cell lines.


Subject(s)
Adenoviridae/genetics , Capsid Proteins/genetics , Genetic Vectors , Lentivirus , Adenoviridae/metabolism , Blotting, Western , Capsid Proteins/biosynthesis , Cell Line, Transformed , Genes, Reporter , Humans , Microscopy, Immunoelectron
15.
J Immunol ; 175(11): 7687-98, 2005 Dec 01.
Article in English | MEDLINE | ID: mdl-16301679

ABSTRACT

Rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) do not express the coxsackie-adenovirus (Ad) receptor and are poorly permissive to Ad serotype 5 (Ad5). Genetically modified, coxsackie-Ad receptor-independent Ad5 vectors were studied for gene delivery in human RA FLS and synovium explants and murine collagen-induced arthritis. Short-fiber Ad5 vectors with seven fiber shaft repeats Ad5GFP-R7-knob, Ad5GFP-R7-arginine-glycine-aspartic acid (RGD) (RGD-liganded), and Ad5GFPDeltaknob (knob-deleted) were compared with Ad5GFP-FiWT, a conventional wild-type (WT) Ad5 vector. Gene transfer by Ad5GFP-R7-knob and Ad5GFP-R7-RGD was 40- to 50-fold and 25-fold higher, respectively, than Ad5GFP-FiWT in FLS. Ad5GFPDeltaknob was more efficacious than its knob-bearing version Ad5GFP-R7-knob in FLS transduction. Virus attachment and entry required RGD- and LDV-binding integrins including alpha(v), alpha(v)beta3, a(v)beta5, and beta1. Ad5GFP-R7-knob infection of FLS was partially neutralized by synovial fluid (SF), but remained 30- to 40-fold higher than Ad5GFP-FiWT in the presence of SF. Ad5GFPDeltaknob was partially neutralized by SF at low virus input, but escaped viral neutralization by SF at higher virus input. Gene transfer to human synovium ex vivo explants and murine collagen-induced arthritis in vivo was also more efficient with short fiber-modified vectors (with and without the knob domain) than Ad5GFPFiWT. Gene transfer by short fiber-modified vectors was enhanced by inflammatory cytokines in vitro and in the presence of inflammation in murine synovium in vivo. Our data indicated that the highly efficient gene delivery RA was mediated by RGD- and non-RGD-binding integrins and enhanced by inflammation. Short fiber modifications with knob ablation may be a strategy to enhance gene delivery, reducing vector dose and vector-induced inflammation and toxicity.


Subject(s)
Arthritis, Rheumatoid/therapy , Genetic Therapy/methods , Integrins/genetics , Oligopeptides/genetics , Synovial Membrane/physiology , Transduction, Genetic/methods , Adenoviridae/genetics , Animals , Cytokines/immunology , Disease Models, Animal , Genetic Vectors , Humans , Inflammation/immunology , Mice , Organ Culture Techniques , Receptors, Virus/genetics , Synovial Membrane/cytology , Synovial Membrane/virology
16.
J Mol Biol ; 352(1): 125-38, 2005 Sep 09.
Article in English | MEDLINE | ID: mdl-16081097

ABSTRACT

Recombinant hexons from subgroup C adenoviruses (Ad2 and Ad5) and from a member of subgroup B (Ad3) adenoviruses have been expressed in insect cells. When expressed alone, all three hexons were found to be insoluble and accumulated as inclusion bodies in the cytoplasm. However, co-expression of recombinant Ad2, Ad5 or Ad3 hexon with Ad2 L4-100K protein resulted in the formation of soluble trimeric hexons. EM analysis of hexons revealed that they were indistinguishable from native hexon capsomers isolated from Ad2-infected human cells, or released from partially disrupted adenovirions. This suggests that 100K acts as a chaperone for hexon folding and self-assembly into capsomer in insect cells. Since 100K protein assists in the trimerization of subgroup C hexon, and of subgroup B hexon protein, it implies that it functions in a manner that is both homo- and heterotypic. During the course of recombinant protein expression, the 100K protein was found in association with hexon monomers and trimers within the cytoplasm. In the nucleus, however, 100K was found in complexes with hexon trimers exclusively. EM observation of purified 100K protein samples showed a dumb-bell-shaped molecule compatible with a monomeric protein. EM analysis of hexon-100K protein complexes showed that interaction of hexon with the 100K protein occurred via one of the globular domains of the 100K protein molecule. Our data confirm the role of the 100K protein as a scaffold protein for hexon, and provide evidence suggesting its function in hexon nuclear import in insect cells.


Subject(s)
Adenoviridae/metabolism , Capsid Proteins/metabolism , Molecular Chaperones/metabolism , Adenoviridae/chemistry , Adenoviridae/classification , Adenoviridae/ultrastructure , Animals , Antigens, Viral/chemistry , Antigens, Viral/metabolism , Capsid/chemistry , Capsid/ultrastructure , Capsid Proteins/chemistry , Cells, Cultured , Humans , Insecta , Molecular Chaperones/chemistry , Molecular Weight , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Time Factors
17.
J Virol ; 78(13): 7227-47, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15194799

ABSTRACT

Monolayers of cystic fibrosis transmembrane conductance regulator (CFTR)-deficient human tracheal glandular cells (CF-KM4) were subjected to phage biopanning, and cell-internalized phages were isolated and sequenced, in order to identify CF-KM4-specific peptide ligands that would confer upon adenovirus type 5 (Ad5) vector a novel cell target specificity and/or higher efficiency of gene delivery into airway cells of patients with cystic fibrosis (CF). Three different ligands, corresponding to prototypes of the most represented families of phagotopes recovered from intracellular phages, were designed and individually inserted into Ad5-green fluorescent protein (GFP) (AdGFP) vectors at the extremities of short fiber shafts (seven repeats [R7]) terminated by scissile knobs. Only one vector, carrying the decapeptide GHPRQMSHVY (abbreviated as QM10), showed an enhanced gene transduction of CF-KM4 cells compared to control nonliganded vector with fibers of the same length (AdGFP-R7-knob). The enhancement in gene transfer efficiency was not specific to CF-KM4 cells but was observed in other mammalian cell lines tested. The QM10-liganded vector was referred to as AdGFP-QM10-knob in its knobbed version and as AdGFP-QM10 in its proteolytically deknobbed version. AdGFP-QM10 was found to transduce cells with a higher efficiency than its knob-bearing version, AdGFP-QM10-knob. Consistent with this, competition experiments indicated that the presence of knob domains was not an absolute requirement for cell attachment of the QM10-liganded vector and that the knobless AdGFP-QM10 used alternative cell-binding domains on its capsid, including penton base capsomer, via a site(s) different from its RGD motifs. The QM10-mediated effect on gene transduction seemed to take place at the step of endocytosis in both quantitative and qualitative manners. Virions of AdGFP-QM10 were endocytosed in higher numbers than virions of the control vector and were directed to a compartment different from the early endosomes targeted by members of species C Ad. AdGFP-QM10 was found to accumulate in late endosomal and low-pH compartments, suggesting that QM10 acted as an endocytic ligand of the lysosomal pathway. These results validated the concept of detargeting and retargeting Ad vectors via our deknobbing system and redirecting Ad vectors to an alternative endocytic pathway via a peptide ligand inserted in the fiber shaft domain.


Subject(s)
Adenoviruses, Human/pathogenicity , Capsid Proteins/genetics , Endocytosis , Genetic Vectors , Peptides/genetics , Transduction, Genetic , Adenoviruses, Human/genetics , Adenoviruses, Human/metabolism , Capsid Proteins/metabolism , Cell Line , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Gene Transfer Techniques , Humans , Ligands , Peptides/chemistry , Receptors, Virus , Trachea/cytology
18.
Mol Ther ; 7(5 Pt 1): 692-9, 2003 May.
Article in English | MEDLINE | ID: mdl-12718912

ABSTRACT

We developed a new type of adenovirus type 5 (Ad5)-derived vector with genetically modified fiber proteins whose knob domains could be stripped off due to the insertion of a single Factor Xa cleavage site in the fiber shaft, between a cellular ligand and the knob domain. This Ad vector did not require a specific cell line for propagation and could be grown in HEK-293 cells. Stripping off the knob domains removed the endogenous cell-binding moiety of Ad but retained the new cell ligand for retargeting purposes. As experimental models for cell ligands, we used two peptides with different sequence complexities: (i) the integrin-binding tripeptide RGD and (ii) a 58-residue oligopeptide termed affibody (Zwt). Zwt binds specifically to the human IgG1 Fc domain or to its Fc3(1) homolog. The modified fibers were efficiently encapsidated into virions, and the Factor Xa sites were fully accessible to proteolysis. In vitro binding assays using recombinant Fc3(1) protein and Ad5-mediated gene transduction of Fc3(1)-expressing cells demonstrated that the proteolytically deknobbed Ad5-Zwt vector was functional and specific for receptor targeting.


Subject(s)
Adenoviridae/genetics , Gene Transfer Techniques , Genetic Vectors , Ligands , Cell Line , Factor Xa/pharmacology , Humans , Protein Folding , Recombinant Proteins , Recombination, Genetic , Staphylococcal Protein A/chemistry , Staphylococcal Protein A/genetics , Transduction, Genetic , Virion/genetics , Virion/growth & development , Virion/pathogenicity , Virus Replication/genetics
19.
J Gene Med ; 4(4): 356-70, 2002.
Article in English | MEDLINE | ID: mdl-12124978

ABSTRACT

BACKGROUND: We studied the ability of adenovirus type 5 (Ad5) to encapsidate new cellular ligands carried by their fibers to yield functional retargeted vectors for gene therapy. Recombinant Ad5 fibers containing shaft repeats 1 to 7 and an extrinsic trimerization motif, and terminated by its native knob or amino acid motifs containing RGD, have been rescued into infectious virions. METHODS: Polypeptide ligands of cell surface molecules, including single-chain antibodies or epidermal growth factor, were cloned into recombinant fibers. Phenotypic analysis of fiber constructs and rescuing into the Ad5 genome were performed. Recombinant viruses were characterized with reference to fiber content, growth rate and infectivity. RESULTS: A major limiting factor for recovering viable recombinant Ad5 carrying fiber-fused polypeptide ligands was apparently the ability of the ligand to fold correctly within the cellular cytoplasm. This constraint has previously not been systematically evaluated in the literature. Phenotypic analysis of the fiber-ligand fusions showed that their degree of cytoplasmic solubility correlated with their ability to yield viable Ad5 vectors. Our results suggested that the fiber manipulations diminish virus growth rate, probably through different, opposing effects: (i) the reduced shaft length increases fiber solubility in the absence of the knob but (ii) diminishes virus entry, and (iii) the absence of the knob alters the overall protein composition of the virion and decreases its fiber copy number. CONCLUSIONS: Based on our findings, cytoplasmic solubility and cytoplasmic ligand reactivity of fiber-ligand fusion proteins are the best prediction criterion for viability and recovery of genetically retargeted Ad vectors.


Subject(s)
Adenoviridae , Genetic Vectors , Animals , COS Cells , Fluorescent Antibody Technique , Gene Transfer Techniques , Humans , Immunoglobulin Fragments/genetics , Ligands
SELECTION OF CITATIONS
SEARCH DETAIL
...